What Is a CRL? Why One FDA Rejection Letter Can Reset an Entire Biotech Story
CRL stands for Complete Response Letter. It is the FDA’s formal response when the agency decides it cannot approve a drug application in its current form. In biotech, that usually means the review did not end with approval and the company now has to address the FDA’s concerns before moving forward.